Do you want to read an article? Please log in or register.
Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort
Further Publications
Related content
Inflammatory Bowel Disease
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis
J Crohns Colitis
D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S
doi: 10.1093/ecco-jcc/jjaf080
RECOMMENDED
Inflammatory Bowel Disease
Incidence, disease burden and clinical presentation of patients newly diagnosed with inflammatory bowel disease in a population-based inception cohort
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Attauabi M, Madsen GR, Bendtsen F, Seidelin JB, Burisch J
doi: 10.1093/ecco-jcc/jjae176
Inflammatory Bowel Disease
Changes in endoscopic activity and classification of lesions with panenteric capsule endoscopy in patients treated for Crohn's disease - a prospective blinded comparison with ileocolonoscopy, faecal calprotectin and C-reactive protein
J Crohns Colitis
Brodersen JB, Kjeldsen J, Juel MA, Knudsen T, Rafaelsen SR, Jensen MD
doi: 10.1093/ecco-jcc/jjae124
Inflammatory Bowel Disease
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study
Am J Gastroenterol
Lee SD, Vermeire S, Ungaro R, Vadhariya A, Durand F, Morris N, Yu G, Fisher DA, Traxler K, Long M
doi: 10.14309/ajg.0000000000003410
Inflammatory Bowel Disease
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn's Disease and Ulcerative Colitis: 2-Year Results from Open-Label Extensions of Two Randomized Controlled Trials (LIBERTY)
J Crohns Colitis
Colombel JF, Sandborn WJ, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Kim JM, Park G, Lee J, Lee J, Ryu JY, Sands BE, Hanauer SB
doi: 10.1093/ecco-jcc/jjaf060
Inflammatory Bowel Disease
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease
Insights Imaging
Sakai NS, Plumb AA, Ahmed N, Chowdhury K, Kilic Y, Hameed M, Patel A, Bhagwanani A, Helbren E, Hyland R, Bhatnagar G, Sidhu H, Lambie H, Franklin JM, Mohsin M, Thomson E, Boone D, Tolan D, Rahman S, Ding N, Moran GW, Bloom S, Hart A, Menys A, Travis S, Halligan S, Taylor SA, Motility trial investigators
doi: 10.1186/s13244-025-01930-w
Inflammatory Bowel Disease
The Natural History of Crohn's Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018
J Crohns Colitis
Wu TH, Brandt CF, Scheike T, Burisch J, Jeppesen PB
doi: 10.1093/ecco-jcc/jjae114
Inflammatory Bowel Disease
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
Inflamm Bowel Dis
Gebeyehu GG, Broglio G, Liu E, Limdi JK, Selinger C, Fiske J, Razanskaite V, Smith PJ, Flanagan PK, Subramanian S
doi: 10.1093/ibd/izae174
COMMENTED
Inflammatory Bowel Disease
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease - a Copenhagen IBD Cohort Study
★ 1
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol
Madsen GR, Attauabi M, Ilvemark JFKF, Theede K, Bjerrum JT, Bendtsen F, Seidelin JB, Wilkens R, Boysen T, Burisch J
doi: 10.1016/j.cgh.2024.12.030